148 related articles for article (PubMed ID: 1673088)
21. [Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow].
Kremens B; Combaret V; Favrot MC; Laurent JC; Philip T
Monatsschr Kinderheilkd; 1990 Jun; 138(6):331-6. PubMed ID: 2197550
[TBL] [Abstract][Full Text] [Related]
22. Purging breast cancer cells in preparation for autologous bone marrow transplantation.
Morecki S; Pavlotzky F; Margel S; Slavin S
Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143
[TBL] [Abstract][Full Text] [Related]
23. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
24. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
25. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
27. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
[TBL] [Abstract][Full Text] [Related]
28. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Morecki S; Slavin S
Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
[TBL] [Abstract][Full Text] [Related]
29. Introduction: workshop summary of the CD15 monoclonal antibody panel from the Fifth International Workshop on Leukocyte Antigens.
Ball ED
Eur J Morphol; 1995 Apr; 33(2):95-100. PubMed ID: 7488522
[TBL] [Abstract][Full Text] [Related]
30. Immunomagnetic manipulation of bone marrow and tumour cells: an update.
Kemshead JT; Elsom G; Patel K
Prog Clin Biol Res; 1990; 333():235-50; discussion 251. PubMed ID: 2408061
[TBL] [Abstract][Full Text] [Related]
31. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
32. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
33. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
[No Abstract] [Full Text] [Related]
34. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.
Tyer CL; Vredenburgh JJ; Heimer M; Peters WP; Bast RC
Clin Cancer Res; 1996 Jan; 2(1):81-6. PubMed ID: 9816094
[TBL] [Abstract][Full Text] [Related]
36. Stem cell selection--clinical experience.
Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
[TBL] [Abstract][Full Text] [Related]
37. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
38. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
39. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
40. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]